Correction to: Efficacy of canakinumab as first-line biologic agent in adult-onset Still’s disease

Detalles Bibliográficos
Autores principales: Cavalli, Giulio, Tomelleri, Alessandro, De Luca, Giacomo, Campochiaro, Corrado, Dinarello, Charles A., Baldissera, Elena, Dagna, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388469/
https://www.ncbi.nlm.nih.gov/pubmed/30803447
http://dx.doi.org/10.1186/s13075-019-1850-x
_version_ 1783397770238885888
author Cavalli, Giulio
Tomelleri, Alessandro
De Luca, Giacomo
Campochiaro, Corrado
Dinarello, Charles A.
Baldissera, Elena
Dagna, Lorenzo
author_facet Cavalli, Giulio
Tomelleri, Alessandro
De Luca, Giacomo
Campochiaro, Corrado
Dinarello, Charles A.
Baldissera, Elena
Dagna, Lorenzo
author_sort Cavalli, Giulio
collection PubMed
description
format Online
Article
Text
id pubmed-6388469
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63884692019-03-19 Correction to: Efficacy of canakinumab as first-line biologic agent in adult-onset Still’s disease Cavalli, Giulio Tomelleri, Alessandro De Luca, Giacomo Campochiaro, Corrado Dinarello, Charles A. Baldissera, Elena Dagna, Lorenzo Arthritis Res Ther Correction BioMed Central 2019-02-25 2019 /pmc/articles/PMC6388469/ /pubmed/30803447 http://dx.doi.org/10.1186/s13075-019-1850-x Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Correction
Cavalli, Giulio
Tomelleri, Alessandro
De Luca, Giacomo
Campochiaro, Corrado
Dinarello, Charles A.
Baldissera, Elena
Dagna, Lorenzo
Correction to: Efficacy of canakinumab as first-line biologic agent in adult-onset Still’s disease
title Correction to: Efficacy of canakinumab as first-line biologic agent in adult-onset Still’s disease
title_full Correction to: Efficacy of canakinumab as first-line biologic agent in adult-onset Still’s disease
title_fullStr Correction to: Efficacy of canakinumab as first-line biologic agent in adult-onset Still’s disease
title_full_unstemmed Correction to: Efficacy of canakinumab as first-line biologic agent in adult-onset Still’s disease
title_short Correction to: Efficacy of canakinumab as first-line biologic agent in adult-onset Still’s disease
title_sort correction to: efficacy of canakinumab as first-line biologic agent in adult-onset still’s disease
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388469/
https://www.ncbi.nlm.nih.gov/pubmed/30803447
http://dx.doi.org/10.1186/s13075-019-1850-x
work_keys_str_mv AT cavalligiulio correctiontoefficacyofcanakinumabasfirstlinebiologicagentinadultonsetstillsdisease
AT tomellerialessandro correctiontoefficacyofcanakinumabasfirstlinebiologicagentinadultonsetstillsdisease
AT delucagiacomo correctiontoefficacyofcanakinumabasfirstlinebiologicagentinadultonsetstillsdisease
AT campochiarocorrado correctiontoefficacyofcanakinumabasfirstlinebiologicagentinadultonsetstillsdisease
AT dinarellocharlesa correctiontoefficacyofcanakinumabasfirstlinebiologicagentinadultonsetstillsdisease
AT baldisseraelena correctiontoefficacyofcanakinumabasfirstlinebiologicagentinadultonsetstillsdisease
AT dagnalorenzo correctiontoefficacyofcanakinumabasfirstlinebiologicagentinadultonsetstillsdisease

Ejemplares similares